The authors examine the potential role of circulating tumor DNA as a clinical tool to inform clinical decision-making from early to late stage cutaneous melanoma.
[Current Oncology Reports]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.